Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | C5AR1 | P21730 | 2/20 | 0.54 |
| ▸ | GHSR | Q92847 | 9/20 | 0.53 |
| ▸ | TUBB4A | P04350 | 1/20 | 0.52 |
| ▸ | TUBB | P07437 | 1/20 | 0.52 |
| ▸ | TUBA3C | P0DPH7 | 1/20 | 0.52 |
| ▸ | TUBA1B | P68363 | 1/20 | 0.52 |
| ▸ | TUBA4A | P68366 | 1/20 | 0.52 |
| ▸ | TUBB4B | P68371 | 1/20 | 0.52 |
| ▸ | TUBB3 | Q13509 | 1/20 | 0.52 |
| ▸ | TUBB2A | Q13885 | 1/20 | 0.52 |
| ▸ | TUBB8 | Q3ZCM7 | 1/20 | 0.52 |
| ▸ | TUBA3E | Q6PEY2 | 1/20 | 0.52 |
| ▸ | TUBA1A | Q71U36 | 1/20 | 0.52 |
| ▸ | TUBA1C | Q9BQE3 | 1/20 | 0.52 |
| ▸ | TUBB6 | Q9BUF5 | 1/20 | 0.52 |
| ▸ | TUBB2B | Q9BVA1 | 1/20 | 0.52 |
| ▸ | TUBB1 | Q9H4B7 | 1/20 | 0.52 |
| ▸ | CD47 | Q08722 | 1/20 | 0.49 |
| ▸ | IL23R | Q5VWK5 | 1/20 | 0.49 |
| ▸ | UTS2R | Q9UKP6 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29540710 | 0.97 | C5AR1 (0.58) | C5AR1GHSRTUBB4ATUBBTUBA3C | |
| SCHEMBL31140223 | 0.96 | TUBB4A (0.56) | C5AR1GHSRTUBB4ATUBBTUBA3C | |
| SCHEMBL29476447 | 0.95 | MC4R (0.50) | C5AR1GHSRTUBB4ATUBBTUBA3C | |
| SCHEMBL29476484 | 0.95 | MC4R (0.50) | C5AR1GHSRTUBB4ATUBBTUBA3C | |
| SCHEMBL30510360 | 0.95 | C5AR1 (0.58) | C5AR1CD47IL23RMC4R | |
| SCHEMBL30878115 | 0.95 | GHSR (0.57) | C5AR1GHSRTUBB4ATUBBTUBA3C | |
| SCHEMBL29384877 | 0.93 | C5AR1 (0.55) | C5AR1GHSRTUBB4ATUBBTUBA3C | |
| SCHEMBL29973131 | 0.93 | C5AR1 (0.55) | C5AR1GHSRTUBB4ATUBBTUBA3C | |
| SCHEMBL30463394 | 0.93 | IL23R (0.57) | C5AR1TUBB4ATUBBTUBA3CTUBA1B | |
| SCHEMBL29672885 | 0.93 | IL23R (0.57) | C5AR1TUBB4ATUBBTUBA3CTUBA1B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 27 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114349827-A | Synthetic method of brennuo peptide | 江苏诺泰澳赛诺生物制药股份有限公司 | 2022-04-15 | — | — | CN | claimed |
| CN-122074077-A | Radiolabeled melanocortin 1 receptor-specific alpha-melanocyte stimulating hormone analogs for imaging or therapy | 省卫生服务机构 | 2026-05-22 | — | — | CN | disclosed |
| EP-4644406-A1 | RADIOLABELED MEDICINE | National University Corporation Chiba University (JP) | 2025-11-05 | — | — | EP | disclosed |
| CN-119775187-A | Melanocortin-4 receptor agonists | 株式会社LG化学 | 2025-04-08 | — | — | CN | disclosed |
| CN-113939500-B | Melanocortin-4 receptor agonists | 株式会社LG化学 | 2024-11-05 | — | — | CN | disclosed |
| WO-2024143314-A1 | RADIOLABELED MEDICINE | 国立大学法人千葉大学 | 2024-07-04 | — | — | WO | disclosed |
| CN-113621022-B | Synthesis method of cyclic peptide | 甘肃瑞德林生物有限公司 | 2024-05-28 | — | — | CN | disclosed |
| CN-117255786-A | Crystalline form VII of melanocortin receptor agonist compound and process for preparing same | 株式会社LG 化学 | 2023-12-19 | — | — | CN | disclosed |
| CN-117255788-A | Crystal form IV of organic acid salt of melanocortin receptor agonist compound and preparation method thereof | 株式会社LG化学 | 2023-12-19 | — | — | CN | disclosed |
| CN-117255787-A | Sulfate crystals of melanocortin receptor agonist compounds and methods of making the same | 株式会社LG 化学 | 2023-12-19 | — | — | CN | disclosed |
| CN-116507614-A | Crystal form IV of melanocortin receptor agonist compound and preparation method thereof | 株式会社LG化学 | 2023-07-28 | — | — | CN | disclosed |
| CN-116507615-A | Crystalline form I of melanocortin receptor agonist compound and process for preparing same | 株式会社LG化学 | 2023-07-28 | — | — | CN | disclosed |
| CN-116490497-A | Crystalline form II of melanocortin receptor agonist compound and process for preparing same | 株式会社LG化学 | 2023-07-25 | — | — | CN | disclosed |
| CN-116419757-A | Amorphous melanocortin-4 receptor agonists | 株式会社LG化学 | 2023-07-11 | — | — | CN | disclosed |
| CN-116143881-A | Preparation method of bumenopeptide | 深圳市健元医药科技有限公司 | 2023-05-23 | — | — | CN | disclosed |
| US-20230101963-A1 | TREATMENT OF MEDICAL INDICATION | VALLAURIX TRADING SARL MC (MC) | 2023-03-30 | — | — | US | disclosed |
| CN-115515617-A | Diamine-linked receptor-specific cyclic peptides | 帕拉丁科技公司 | 2022-12-23 | — | — | CN | disclosed |
| EP-4100040-A1 | DIAMINE-LINKED RECEPTOR-SPECIFIC CYCLIC PEPTIDES | Palatin Technologies, Inc. (US) | 2022-12-14 | — | — | EP | disclosed |
| CN-112587651-B | Oral pharmaceutical composition of Bremelanotide and application thereof | 北京汇诚瑞祥医药生物科技有限公司 | 2022-05-13 | — | — | CN | disclosed |
| CN-114349827-A | Synthetic method of brennuo peptide | 江苏诺泰澳赛诺生物制药股份有限公司 | 2022-04-15 | — | — | CN | disclosed |